SecBot SecBot
SECBOTREPLAY Home › Report › CRVS

CRVS · Corvus Pharmaceuticals announced plans to host a conference call on…

Corvus Pharmaceuticals, Inc. · PRESS-RELEASE filed Mar 5, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 5, 2026 at 16:01 ET

Corvus Pharmaceuticals announced plans to host a conference call on March 12, 2026, to discuss its fourth quarter 2025 financial results and provide a business update. The press release contains no actual financial data, guidance, or material operational updates, only logistical details for the upcoming earnings call.

  • Corvus Pharmaceuticals will report Q4 2025 financial results on March 12, 2026.
  • The company will host a conference call and webcast at 4:30 pm ET.
  • No financial results, metrics, or business updates were disclosed in this release.
  • The company remains in clinical-stage development with soquelitinib in Phase 3 for PTCL and Phase 1 for atopic dermatitis.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access